Page last updated: 2024-08-26

fulvestrant and navitoclax

fulvestrant has been researched along with navitoclax in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cook, RS; Duvall, C; Elion, D; Elledge, R; Estrada, MV; Hicks, DJ; Joly, MMM; Lee, L; Massarweh, S; McKernan, C; Rahman, B; Sanchez, V; Werfel, T; Williams, MM	1
Cheung, P; Kakit, C; Kiess, N; Parsons, R; Pegno, S; Poulikakos, PI; Schmidt, H; Stratikopoulos, EE; Szabolcs, M; Wu, X	1

Other Studies

2 other study(ies) available for fulvestrant and navitoclax

Article	Year
Intrinsic apoptotic pathway activation increases response to anti-estrogens in luminal breast cancers. Cell death & disease, 2018, 01-17, Volume: 9, Issue:2 Topics: Aniline Compounds; Animals; Apoptosis; bcl-X Protein; Breast Neoplasms; Cell Line, Tumor; Down-Regulation; Estrogen Antagonists; Female; Fulvestrant; Gene Targeting; Humans; Mice; Myeloid Cell Leukemia Sequence 1 Protein; Receptors, Estrogen; Signal Transduction; Sulfonamides; Up-Regulation	2018
Mouse ER+/PIK3CA Oncogene, 2019, Volume: 38, Issue:1 Topics: Aniline Compounds; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; BH3 Interacting Domain Death Agonist Protein; Cell Line, Tumor; Class I Phosphatidylinositol 3-Kinases; Cocarcinogenesis; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Estradiol; Estrogen Receptor alpha; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Gene Knock-In Techniques; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Mutation, Missense; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Neuropeptides; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Sulfonamides; Thiazoles	2019

Article

Year

Intrinsic apoptotic pathway activation increases response to anti-estrogens in luminal breast cancers.

Cell death & disease, 2018, 01-17, Volume: 9, Issue:2

Topics: Aniline Compounds; Animals; Apoptosis; bcl-X Protein; Breast Neoplasms; Cell Line, Tumor; Down-Regulation; Estrogen Antagonists; Female; Fulvestrant; Gene Targeting; Humans; Mice; Myeloid Cell Leukemia Sequence 1 Protein; Receptors, Estrogen; Signal Transduction; Sulfonamides; Up-Regulation

2018

Mouse ER+/PIK3CA

Oncogene, 2019, Volume: 38, Issue:1

Topics: Aniline Compounds; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; BH3 Interacting Domain Death Agonist Protein; Cell Line, Tumor; Class I Phosphatidylinositol 3-Kinases; Cocarcinogenesis; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Estradiol; Estrogen Receptor alpha; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Gene Knock-In Techniques; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Mutation, Missense; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Neuropeptides; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Sulfonamides; Thiazoles

2019